These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12847283)

  • 1. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis.
    Leali D; Dell'Era P; Stabile H; Sennino B; Chambers AF; Naldini A; Sozzani S; Nico B; Ribatti D; Presta M
    J Immunol; 2003 Jul; 171(2):1085-93. PubMed ID: 12847283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes.
    Naldini A; Leali D; Pucci A; Morena E; Carraro F; Nico B; Ribatti D; Presta M
    J Immunol; 2006 Oct; 177(7):4267-70. PubMed ID: 16982859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2.
    Ribatti D; Gualandris A; Belleri M; Massardi L; Nico B; Rusnati M; Dell'Era P; Vacca A; Roncali L; Presta M
    J Pathol; 1999 Dec; 189(4):590-9. PubMed ID: 10629563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis.
    Ribatti D; Nico B; Morbidelli L; Donnini S; Ziche M; Vacca A; Roncali L; Presta M
    J Vasc Res; 2001; 38(4):389-97. PubMed ID: 11455210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth.
    Hirama M; Takahashi F; Takahashi K; Akutagawa S; Shimizu K; Soma S; Shimanuki Y; Nishio K; Fukuchi Y
    Cancer Lett; 2003 Jul; 198(1):107-17. PubMed ID: 12893437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement.
    Leali D; Moroni E; Bussolino F; Presta M
    J Biol Chem; 2007 Jul; 282(27):19676-84. PubMed ID: 17456474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells.
    Dell'Era P; Belleri M; Stabile H; Massardi ML; Ribatti D; Presta M
    Oncogene; 2001 May; 20(21):2655-63. PubMed ID: 11420677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived osteopontin is soluble, not matrix associated.
    Rittling SR; Chen Y; Feng F; Wu Y
    J Biol Chem; 2002 Mar; 277(11):9175-82. PubMed ID: 11741994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Senger DR; Ledbetter SR; Claffey KP; Papadopoulos-Sergiou A; Peruzzi CA; Detmar M
    Am J Pathol; 1996 Jul; 149(1):293-305. PubMed ID: 8686754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
    Liekens S; Neyts J; De Clercq E; Verbeken E; Ribatti D; Presta M
    Cancer Res; 2001 Jul; 61(13):5057-64. PubMed ID: 11431341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
    Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
    Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen.
    Geissinger E; Weisser C; Fischer P; Schartl M; Wellbrock C
    Cancer Res; 2002 Aug; 62(16):4820-8. PubMed ID: 12183442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin induces angiogenesis of murine neuroblastoma cells in mice.
    Takahashi F; Akutagawa S; Fukumoto H; Tsukiyama S; Ohe Y; Takahashi K; Fukuchi Y; Saijo N; Nishio K
    Int J Cancer; 2002 Apr; 98(5):707-12. PubMed ID: 11920639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profile in fibroblast growth factor 2-transformed endothelial cells.
    Dell'Era P; Coco L; Ronca R; Sennino B; Presta M
    Oncogene; 2002 Apr; 21(15):2433-40. PubMed ID: 11948428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
    Rusnati M; Camozzi M; Moroni E; Bottazzi B; Peri G; Indraccolo S; Amadori A; Mantovani A; Presta M
    Blood; 2004 Jul; 104(1):92-9. PubMed ID: 15031207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
    Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
    Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pro-inflammatory signature mediates FGF2-induced angiogenesis.
    Andrés G; Leali D; Mitola S; Coltrini D; Camozzi M; Corsini M; Belleri M; Hirsch E; Schwendener RA; Christofori G; Alcamì A; Presta M
    J Cell Mol Med; 2009 Aug; 13(8B):2083-2108. PubMed ID: 18624773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
    Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
    Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay.
    Ribatti D; Gualandris A; Bastaki M; Vacca A; Iurlaro M; Roncali L; Presta M
    J Vasc Res; 1997; 34(6):455-63. PubMed ID: 9425998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of IL-18 as a novel angiogenic mediator.
    Park CC; Morel JC; Amin MA; Connors MA; Harlow LA; Koch AE
    J Immunol; 2001 Aug; 167(3):1644-53. PubMed ID: 11466388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.